The Valley Desk

NCT05425576 · Interventional trial

OT-101 in Combination With Pembrolizumab in Subjects With Malignant Pleural Mesothelioma Failing to Respond to Checkpoint Inhibition

Overall registry status Not yet recruiting

Phase 2

Conditions Malignant Pleural Mesothelioma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov